KSCL vs NATHBIOGEN: Stock Comparison
Kaveri Seed Company Limited vs Nath Bio-Genes (India) Limited
Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings
Kaveri Seed Company Limited is the larger company by market capitalisation. Kaveri Seed Company Limited shows a higher ROE, faster revenue growth and lower leverage, while Nath Bio-Genes (India) Limited shows a lower P/E and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Side-by-side comparison of Kaveri Seed Company Limited and Nath Bio-Genes (India) Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | KSCL | NATHBIOGEN |
|---|---|---|
| Sector | Fast Moving Consumer Goods | Fast Moving Consumer Goods |
| Industry | Other Agricultural Products | Other Agricultural Products |
Price
| Metric | KSCL | NATHBIOGEN |
|---|---|---|
| Live Price | ₹835.5 | ₹161.13 |
| Day Change | 0.81% | 4.19% |
| Volume | 34,869 | 19,108 |
| 52-Week High | ₹1,225 | ₹204 |
| 52-Week Low | ₹705.1 | ₹126.15 |
| Distance from 52W High | -31.8% | -21.01% |
Valuation
| Metric | KSCL | NATHBIOGEN |
|---|---|---|
| Market Cap | ₹4,292 Cr | ₹301 Cr |
| P/E Ratio | 14.5x | 7.43x |
| P/B Ratio | 2.44x | 0.45x |
| EPS | ₹56.96 | ₹20.97 |
| Book Value | ₹414.42 | ₹304.36 |
| Dividend Yield | 0.58% | 1.23% |
Growth
| Metric | KSCL | NATHBIOGEN |
|---|---|---|
| Revenue Growth (TTM YoY) | 18.7% | -1% |
| EPS Growth (TTM YoY) | 0% | 0% |
| Qtr Sales Growth | 18.7% | -0.73% |
| Qtr Profit Growth | -21.2% | -101% |
Profitability & Leverage
| Metric | KSCL | NATHBIOGEN |
|---|---|---|
| ROE | 18.2% | 5.47% |
| ROCE | 18.8% | 7.1% |
| Net Margin | 21.21% | 9.35% |
| Operating Margin | 24.2% | 11.8% |
| Debt to Equity | 0x | 0.2x |
Shareholding
As of Mar 2026 • change vs previous quarter| Metric | KSCL | NATHBIOGEN |
|---|---|---|
| Promoter Holding | 60.5% | 45.6% |
| FII Holding | 18.55%▼ 1.4 pp | 0.23%▼ 0.08 pp |
| DII Holding | 2.87%▲ 0.09 pp | 0.01% |
| Public Holding | 17.31%▲ 1.89 pp | 54.17%▲ 0.09 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Kaveri Seed Company Limited and Nath Bio-Genes (India) Limited.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.